Aveanna Healthcare (NASDAQ:AVAH) Given New $5.00 Price Target at Deutsche Bank Aktiengesellschaft

Aveanna Healthcare (NASDAQ:AVAH) had its price objective hoisted by stock analysts at Deutsche Bank Aktiengesellschaft from $3.00 to $5.00 in a research report issued on Friday, Benzinga reports. The firm presently has a “buy” rating on the stock. Deutsche Bank Aktiengesellschaft’s target price points to a potential upside of 6.16% from the company’s current price.

Separately, UBS Group boosted their target price on shares of Aveanna Healthcare from $1.70 to $2.80 and gave the company a “sell” rating in a research report on Friday. Three equities research analysts have rated the stock with a sell rating, one has assigned a hold rating and one has given a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $3.45.

Aveanna Healthcare Price Performance

Shares of Aveanna Healthcare stock traded up $0.17 during trading on Friday, reaching $4.71. 959,390 shares of the company traded hands, compared to its average volume of 138,458. Aveanna Healthcare has a 1-year low of $0.85 and a 1-year high of $5.10. The company has a 50 day moving average price of $3.15 and a 200-day moving average price of $2.68. The firm has a market capitalization of $906.11 million, a PE ratio of -7.85 and a beta of 2.08.

Aveanna Healthcare (NASDAQ:AVAH) last released its earnings results on Thursday, May 9th. The company reported ($0.05) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.06) by $0.01. The company had revenue of $490.65 million for the quarter, compared to analyst estimates of $485.05 million. During the same quarter in the previous year, the firm earned ($0.06) EPS. Equities research analysts expect that Aveanna Healthcare will post -0.13 earnings per share for the current year.

Institutional Trading of Aveanna Healthcare

Hedge funds and other institutional investors have recently bought and sold shares of the business. SG Americas Securities LLC increased its stake in Aveanna Healthcare by 24.6% during the 4th quarter. SG Americas Securities LLC now owns 23,941 shares of the company’s stock valued at $64,000 after purchasing an additional 4,721 shares in the last quarter. Acadian Asset Management LLC grew its stake in shares of Aveanna Healthcare by 185.6% in the 1st quarter. Acadian Asset Management LLC now owns 29,385 shares of the company’s stock worth $72,000 after acquiring an additional 19,096 shares in the last quarter. Bank of New York Mellon Corp grew its stake in shares of Aveanna Healthcare by 6.6% in the 2nd quarter. Bank of New York Mellon Corp now owns 149,761 shares of the company’s stock worth $413,000 after acquiring an additional 9,243 shares in the last quarter. Renaissance Technologies LLC grew its stake in shares of Aveanna Healthcare by 155.8% in the 2nd quarter. Renaissance Technologies LLC now owns 158,600 shares of the company’s stock worth $438,000 after acquiring an additional 96,600 shares in the last quarter. Finally, Vanguard Group Inc. grew its stake in shares of Aveanna Healthcare by 1.8% in the 1st quarter. Vanguard Group Inc. now owns 2,571,251 shares of the company’s stock worth $6,402,000 after acquiring an additional 44,970 shares in the last quarter. Institutional investors own 87.96% of the company’s stock.

Aveanna Healthcare Company Profile

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.